nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS2—osteoarthritis	0.955	1	CbGaD
Meloxicam—Lornoxicam—PTGS2—osteoarthritis	0.00382	0.41	CrCbGaD
Meloxicam—Tenoxicam—PTGS2—osteoarthritis	0.00341	0.365	CrCbGaD
Meloxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00291	0.0821	CbGpPWpGaD
Meloxicam—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00231	0.0651	CbGpPWpGaD
Meloxicam—Piroxicam—PTGS2—osteoarthritis	0.0021	0.226	CrCbGaD
Meloxicam—PTGS1—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00189	0.0533	CbGpPWpGaD
Meloxicam—PTGS2—Eicosanoid Synthesis—PTGES—osteoarthritis	0.0015	0.0423	CbGpPWpGaD
Meloxicam—PGD—Carbohydrate metabolism—FMOD—osteoarthritis	0.00123	0.0348	CbGpPWpGaD
Meloxicam—PTGS1—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00105	0.0296	CbGpPWpGaD
Meloxicam—PTGS2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000833	0.0235	CbGpPWpGaD
Meloxicam—PGD—Carbohydrate metabolism—BGN—osteoarthritis	0.000685	0.0193	CbGpPWpGaD
Meloxicam—CYP2C8—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000678	0.0191	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—CRP—osteoarthritis	0.000666	0.0188	CbGpPWpGaD
Meloxicam—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.00066	0.0186	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—FN1—osteoarthritis	0.000615	0.0174	CbGpPWpGaD
Meloxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—osteoarthritis	0.000613	0.0173	CbGpPWpGaD
Meloxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—osteoarthritis	0.00057	0.0161	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000552	0.0156	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—CRP—osteoarthritis	0.000529	0.0149	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—SOX9—osteoarthritis	0.000514	0.0145	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—HSPA5—osteoarthritis	0.000511	0.0144	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—FN1—osteoarthritis	0.000488	0.0138	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—HSPA5—osteoarthritis	0.000487	0.0137	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—TIMP1—osteoarthritis	0.000487	0.0137	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—TIMP1—osteoarthritis	0.000464	0.0131	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—PTGS2—osteoarthritis	0.000447	0.0126	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000433	0.0122	CbGpPWpGaD
Meloxicam—ABCC4—Ectoderm Differentiation—TNFRSF11B—osteoarthritis	0.000415	0.0117	CbGpPWpGaD
Meloxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	0.000377	0.0106	CbGpPWpGaD
Meloxicam—PTGS1—Eicosanoid Synthesis—PTGS2—osteoarthritis	0.00037	0.0105	CbGpPWpGaD
Meloxicam—PGD—Disease—FMOD—osteoarthritis	0.000349	0.00985	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000344	0.00971	CbGpPWpGaD
Meloxicam—PGD—Disease—IHH—osteoarthritis	0.000311	0.00878	CbGpPWpGaD
Meloxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	0.00031	0.00875	CbGpPWpGaD
Meloxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	0.000303	0.00856	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—TNF—osteoarthritis	0.000301	0.00851	CbGpPWpGaD
Meloxicam—PGD—Metabolism—FMOD—osteoarthritis	0.000292	0.00825	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—FN1—osteoarthritis	0.000276	0.0078	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—GSTO1—osteoarthritis	0.000275	0.00777	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—COL2A1—osteoarthritis	0.000273	0.0077	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—osteoarthritis	0.000263	0.00743	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.000243	0.00688	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—IL6—osteoarthritis	0.000243	0.00687	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—IGF1—osteoarthritis	0.000242	0.00683	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—TNF—osteoarthritis	0.000239	0.00676	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGES—osteoarthritis	0.000238	0.00673	CbGpPWpGaD
Meloxicam—PGD—Disease—TGFBI—osteoarthritis	0.000232	0.00655	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	0.000231	0.00651	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.000227	0.0064	CbGpPWpGaD
Meloxicam—PGD—NRF2 pathway—TGFB1—osteoarthritis	0.000225	0.00636	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.000216	0.0061	CbGpPWpGaD
Meloxicam—PTGS1—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000206	0.00581	CbGpPWpGaD
Meloxicam—PGD—Disease—GSTO1—osteoarthritis	0.0002	0.00566	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—CRP—osteoarthritis	0.000195	0.00552	CbGpPWpGaD
Meloxicam—PGD—Disease—BGN—osteoarthritis	0.000194	0.00548	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—IL6—osteoarthritis	0.000193	0.00545	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—GSTO1—osteoarthritis	0.000178	0.00502	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—GSTO1—osteoarthritis	0.000175	0.00495	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GSTO1—osteoarthritis	0.000168	0.00474	CbGpPWpGaD
Meloxicam—PGD—Metabolism—BGN—osteoarthritis	0.000163	0.00459	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—osteoarthritis	0.000159	0.00448	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—CRP—osteoarthritis	0.000155	0.00438	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00015	0.00424	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL1A—osteoarthritis	0.000147	0.00414	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—TGFB1—osteoarthritis	0.000145	0.0041	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.000145	0.00409	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.000143	0.00403	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	0.000138	0.0039	CbGpPWpGaD
Meloxicam—CYP2C8—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000133	0.00376	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000131	0.0037	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.000123	0.00346	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000122	0.00344	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	0.00012	0.00339	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000119	0.00336	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000118	0.00333	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HSPA5—osteoarthritis	0.000117	0.0033	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TIMP1—osteoarthritis	0.000111	0.00314	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	0.00011	0.00312	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000108	0.00306	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.000107	0.00303	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	9.69e-05	0.00274	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	9.68e-05	0.00273	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	9.54e-05	0.00269	CbGpPWpGaD
Meloxicam—PGD—Disease—SMAD3—osteoarthritis	9.53e-05	0.00269	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	9.41e-05	0.00266	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—TGFB1—osteoarthritis	8.97e-05	0.00253	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	8.84e-05	0.0025	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—FMOD—osteoarthritis	8.2e-05	0.00231	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	7.98e-05	0.00225	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	7.89e-05	0.00223	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	7.8e-05	0.0022	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FMOD—osteoarthritis	7.77e-05	0.00219	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	7.65e-05	0.00216	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	7.22e-05	0.00204	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	7.14e-05	0.00202	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	7.02e-05	0.00198	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IHH—osteoarthritis	6.92e-05	0.00196	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MMP1—osteoarthritis	6.92e-05	0.00195	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	6.75e-05	0.00191	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGES—osteoarthritis	6.68e-05	0.00189	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—FMOD—osteoarthritis	6.51e-05	0.00184	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	6.44e-05	0.00182	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—FN1—osteoarthritis	6.32e-05	0.00178	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	5.95e-05	0.00168	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	5.67e-05	0.0016	CbGpPWpGaD
Meloxicam—PGD—Disease—PTGS2—osteoarthritis	5.58e-05	0.00158	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	5.55e-05	0.00157	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IGF1—osteoarthritis	5.53e-05	0.00156	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTGES—osteoarthritis	5.3e-05	0.0015	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—FMOD—osteoarthritis	5.29e-05	0.00149	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFBI—osteoarthritis	5.16e-05	0.00146	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTO1—osteoarthritis	4.71e-05	0.00133	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—osteoarthritis	4.67e-05	0.00132	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—BGN—osteoarthritis	4.56e-05	0.00129	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	4.48e-05	0.00127	CbGpPWpGaD
Meloxicam—PTGS2—Disease—GSTO1—osteoarthritis	4.46e-05	0.00126	CbGpPWpGaD
Meloxicam—PTGS2—Disease—BGN—osteoarthritis	4.32e-05	0.00122	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGES—osteoarthritis	4.32e-05	0.00122	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—FMOD—osteoarthritis	4.31e-05	0.00122	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	4.05e-05	0.00114	CbGpPWpGaD
Meloxicam—PGD—Disease—TGFB1—osteoarthritis	4.03e-05	0.00114	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	3.78e-05	0.00107	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTO1—osteoarthritis	3.74e-05	0.00106	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—BGN—osteoarthritis	3.62e-05	0.00102	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGES—osteoarthritis	3.51e-05	0.000992	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TGFB1—osteoarthritis	3.32e-05	0.000937	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTO1—osteoarthritis	3.04e-05	0.000859	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—osteoarthritis	3.04e-05	0.000858	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—BGN—osteoarthritis	2.94e-05	0.000832	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.94e-05	0.000831	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—FMOD—osteoarthritis	2.84e-05	0.000802	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTO1—osteoarthritis	2.47e-05	0.000699	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—BGN—osteoarthritis	2.4e-05	0.000677	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGES—osteoarthritis	2.32e-05	0.000654	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SMAD3—osteoarthritis	2.12e-05	0.000599	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.9e-05	0.000537	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTO1—osteoarthritis	1.63e-05	0.000461	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—BGN—osteoarthritis	1.58e-05	0.000446	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.55e-05	0.000437	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—osteoarthritis	1.31e-05	0.00037	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFB1—osteoarthritis	8.98e-06	0.000254	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—osteoarthritis	8.47e-06	0.000239	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—osteoarthritis	6.89e-06	0.000195	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—osteoarthritis	6.77e-06	0.000191	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—osteoarthritis	4.54e-06	0.000128	CbGpPWpGaD
